BTCY logo

Biotricity, Inc. Stock Price

OTCPK:BTCY Community·US$9.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

BTCY Share Price Performance

US$0.33
0.05 (16.73%)
US$0.33
0.05 (16.73%)
Price US$0.33

BTCY Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk and slightly overvalued.

3 Risks
1 Reward

Biotricity, Inc. Key Details

US$15.1m

Revenue

US$3.0m

Cost of Revenue

US$12.0m

Gross Profit

US$16.9m

Other Expenses

-US$4.9m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.17
79.84%
-32.27%
-84.8%
View Full Analysis

About BTCY

Founded
n/a
Employees
46
CEO
Waqaas Al-Siddiq
WebsiteView website
www.biotricity.com

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux and Biocore Pro, an integrated ECG device and software that utilizes wet electrodes for cardiac outpatient monitoring (COM) market; Biocore, a Holter and Extended Holter monitors for cardiac diagnostics; Biocare which support medical practitioners to gather data, and regularly monitor and treat patients with two or more chronic care conditions; Bioheart that offers preventative care and disease management solutions; and Biokit, a remote patient monitoring kit for cardiac patients that had other chronic conditions such as hypertension or COPD. Biotricity, Inc. is based in Redwood City, California.

Recent BTCY News & Updates

Recent updates

No updates